COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
An analysis of Centers for Disease Control and Prevention (CDC) data collected from mid-February to mid-July found nurses predominated among health care professionals (HCPs) who contracted COVID-19.
Last week, the Food and Drug Administration (FDA) issued its first emergency use authorization for a point-of-care COVID-19 antibody test.
Technical guidance to support effective use of antigen tests in various testing situations was updated this week by the Centers for Disease Control and Prevention (CDC). The guidance summarizes the differences between diagnostic, screening, and surveillance testing and provides links to regulatory…
To fulfill its vision that “all people have the opportunity to attain the highest level of health possible,” the Centers for Disease Control and Prevention (CDC) developed a COVID-19 response health equity strategy, which the agency recently updated.
The Centers for Medicare & Medicaid Services (CMS) revised guidance issued in June 2020 transitioning states to routine oversight and survey activities at long-term care facilities after limits had been imposed in response to the COVID-19 pandemic.